Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart imaging study aims to predict cardiac events

NCT ID NCT02792075

Knowledge-focused Sponsor: Seung-Jung Park Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 4000 people with coronary artery disease who have had special imaging of their heart arteries. Researchers will track them for 5 years to see how well the images predict serious events like heart attacks or the need for repeat procedures. The goal is to improve risk assessment and guide future treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better predict heart attacks and guide treatment decisions for people with narrowed arteries.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve health. Results may not apply to everyone with coronary artery disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 4,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2016

Expected to finish

Jun 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with intracoronary imaging

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with intracoronary imaging * Written consent Exclusion Criteria: * Severe calcification and/or severe tortuosity * Lesion with previous bypass graft surgery (CABG) * Left ventricular ejection fraction less than 30 % * Coronary spasm * Life expectancy less than 2 years * Pregnancy or breast-feeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    11 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ajou University Hospital

    ACTIVE_NOT_RECRUITING

    Suwon, South Korea

  • Asan Medical Center

    RECRUITING

    Seoul, Songpa-gu, 138-736, South Korea

  • Chung-Ang university hospital

    RECRUITING

    Seoul, South Korea

  • Chungnam National University Hospital

    RECRUITING

    Daejeon, South Korea

  • Gachon University Gil Hospital

    TERMINATED

    Incheon, South Korea

  • Inje University Busan Paik Hospital

    RECRUITING

    Busan, South Korea

  • Inje University Ilsan Paik Hospital

    RECRUITING

    Ilsan, South Korea

  • Jeju national university hospital

    RECRUITING

    Jeju City, South Korea

  • Kangbuk Samsung Hospital

    WITHDRAWN

    Seoul, South Korea

  • Keimyung University Dongsan Medical Center

    RECRUITING

    Daegu, South Korea

  • Korea University Guro Hospital

    RECRUITING

    Seoul, South Korea

  • Pusan National University Hospital

    RECRUITING

    Pusan, South Korea

  • Soon Chun Hyang University Hospital Cheonan

    RECRUITING

    Cheonan, South Korea

  • Ulsan University Hospital

    WITHDRAWN

    Ulsan, South Korea

  • Wonju Severance Christian Hospital

    RECRUITING

    Wŏnju, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.